Literature DB >> 7598411

Management of ductal carcinoma in situ of the breast.

N J Carty1, C Carter, G T Royle, C D Johnson.   

Abstract

The advent of mammographic breast screening has increased the detection of ductal carcinoma in situ (DCIS), which now accounts for 15-20% of all breast cancer. While symptomatic DCIS has been treated satisfactorily by mastectomy, this may be an overtreatment of smaller screen-detected lesions. Although local excision, with or without radiotherapy, is associated with a significant risk of local recurrence of DCIS or invasive cancer, salvage surgery is usually successful. The long-term breast-specific mortality rate of treatment by mastectomy and local excision are similar. Whereas mastectomy is still appropriate for women with lesions > 30 mm in diameter or centrally placed and for those women who demand the best possible disease-free survival, local surgery should otherwise be considered.

Entities:  

Mesh:

Year:  1995        PMID: 7598411      PMCID: PMC2502099     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  37 in total

Review 1.  In-situ breast cancer: the EORTC consensus meeting.

Authors:  J A van Dongen; I S Fentiman; J R Harris; R Holland; J L Peterse; B Salvadori; H J Stewart
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

Review 2.  Vexed surgeons, perplexed patients, and breast cancers which may not be cancer.

Authors:  A S Ketcham; F L Moffat
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

3.  Specimen-orientated radiography helps define excision margins of malignant lesions detected by breast screening.

Authors:  J M Dixon; O Ravi Sekar; J Walsh; D Paterson; T J Anderson
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

4.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.

Authors:  M D Lagios; F R Margolin; P R Westdahl; M R Rose
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

5.  The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.

Authors:  R Holland; J L Connolly; R Gelman; M Mravunac; J H Hendriks; A L Verbeek; S J Schnitt; B Silver; J Boyages; J R Harris
Journal:  J Clin Oncol       Date:  1990-01       Impact factor: 44.544

6.  Management of screen detected ductal carcinoma in situ of the female breast.

Authors:  R Carpenter; P S Boulter; T Cooke; N M Gibbs
Journal:  Br J Surg       Date:  1989-06       Impact factor: 6.939

7.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.

Authors:  B Fisher; J Costantino; C Redmond; E Fisher; R Margolese; N Dimitrov; N Wolmark; D L Wickerham; M Deutsch; L Ore
Journal:  N Engl J Med       Date:  1993-06-03       Impact factor: 91.245

8.  Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone.

Authors:  G F Schwartz; G C Finkel; J C Garcia; A S Patchefsky
Journal:  Cancer       Date:  1992-11-15       Impact factor: 6.860

9.  Radiotherapy after breast-preserving surgery in women with localized cancer of the breast.

Authors:  U Veronesi; A Luini; M Del Vecchio; M Greco; V Galimberti; M Merson; F Rilke; V Sacchini; R Saccozzi; T Savio
Journal:  N Engl J Med       Date:  1993-06-03       Impact factor: 91.245

10.  Duct carcinoma in situ: 227 cases without microinvasion.

Authors:  M J Silverstein; B F Cohlan; E D Gierson; M Furmanski; P Gamagami; W J Colburn; B S Lewinsky; J R Waisman
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.